Skip to content

Effectiveness of Self-Help for Dually-Diagnosed Persons - 1

Effectiveness of Self-Help for Dually-Diagnosed Persons

Status
Completed
Phases
Phase 1Phase 2
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT00218582
Enrollment
229
Registered
2005-09-22
Start date
2003-03-31
Completion date
2007-03-31
Last updated
2017-01-12

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Dual Diagnosis, Mental Disorders, Substance-Related Disorders

Keywords

12 step groups, self help, psychiatric day treatment, co-occurring disorders, dual diagnosis

Brief summary

The purpose of this study is to determine the effectiveness of adding dual focus 12-step self-help groups to standard treatment to improve behavioral outcomes for patients dually diagnosed with substance abuse and psychiatric disorders.

Interventions

Dual focus 12 step mutual aid groups for persons with co-occurring disorders (psychiatric and substance use disorders), provided within the context of standard psychiatric day treatment

BEHAVIORALStandard psychiatric day treatment

Individual counseling, groups, medication

Sponsors

National Development and Research Institutes, Inc.
CollaboratorOTHER
National Institute on Drug Abuse (NIDA)
Lead SponsorNIH

Study design

Allocation
NON_RANDOMIZED
Intervention model
PARALLEL
Primary purpose
TREATMENT
Masking
NONE

Eligibility

Sex/Gender
ALL
Age
18 Years to 64 Years
Healthy volunteers
No

Inclusion criteria

Admission to psychiatric day treatment program 18-64 years old

Exclusion criteria

Did not understand or speak English, appeared intoxicated on drugs or alcohol, carried a diagnosis of mental retardation, were deemed actively psychotic by the clinic's intake coordinator, appeared unable to understand and give informed consent.

Design outcomes

Primary

MeasureTime frame
drug/alcohol usepast 90 days

Secondary

MeasureTime frame
psychiatric medication adherencerecent
traditional 12 step meeting attendancepast 90 days
psychiatric symptomsrecent
program retentionup to 6 months

Countries

United States

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026